PCP: management of co-infection

Slides:



Advertisements
Similar presentations
Antimicrobial Prescribing in the Management of COPD
Advertisements

Lower Respiratory Tract Infection. Pneumonia Common with high morbidity and mortality rates. Acute respiratory infection with focal chest signs and radiographic.
Autopsies in HIV: still finding missed diagnoses after 20 years Background Mortality has significantly fallen with the advent of HAART and chemoprophylaxis.
1 Tuberculosis: Basics Rick Speare Anton Breinl Centre School of Public Health, Tropical Medicine and Rehabilitation Sciences James Cook University 16.
The Importance of Viral Etiology in Hospitalized Patients with Community Acquired Pneumonia in Jefferson County Martin Gnoni MD, Swetha Kadali, MD, Jorge.
Clinical Care of HIV, AIDS and Opportunistic Infections
Estimating the Burden of Serious Fungal Diseases in Thailand Methee Chayakulkeeree 1, David W. Denning 2* 1 Division of Infectious Diseases and Tropical.
1 Diagnosis of HIV Infection in Children HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
1 30/11/98 Herpes Viruses Cytomegalovirus. 2 30/11/98 Presentation Outline  Structure  Classification  Multiplication  Clinical manifestations  Epidemiology.
Tuberculosis as a cause of death in HIV + patients in Africa: autopsy Autopsies on 108 HIV+ patients in Botswana (selected) Cause of death: Tuberculosis37%
Robin J Green PhD, DSc New Insights into the Bugs in the Airway of HIV-infected Children with Lung Disease.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
A Call to Action Children – The missing face of AIDS.
Comparison between pathogen directed antibiotic treatment and empiri cal broad spectrum antibiotic treatment in patients with community acquired pneumonia.
PREVALENCE OF OSTEOMYELITIS IN HIV INFECTED PATIENTS. PRESENTERS: 1. MOHAMED M. NOORANY- MBChB V (MUSOM) 2. MUKOYA AQUINATA (Sr)- MBChB V (MUSOM) FACILITATORS:
APIC Chapter 13 Journal Club March 16, 2015 Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults NEJM – July 30, :5 Presented.
New WHO algorithm to prevent TB deaths in seriously ill patients with HIV Yohhei Hamada TB/HIV and Community Engagement.
CHILDREN and HIV.
Tuberculosis (TB) PHCL 442 Lab Discussion 4 Raniah Al-Jaizani M.Sc.
5th Semester Classes on Infectious Diseases, 8-9AM, Thursdays (LT-4)
Fever in infants: Evaluation by
Etiology of bacteremia in children under 5 years in Southern Mali
Hospital-Acquired Pneumonia
Pneumonia Salutations:
Table 1. Relevant Investigations
RENAL TRANSPLANTATION IN AN INTENSIVE CARE UNIT:
Fig. 3. Target population for vaccines in the 21st century by Rappuoli et al. [25]. (A) The most important vaccines for each age group are reported. (B)
Relationship between CMV & PU disease
Infections In The Immunocompromised Host
Agents of nosocomial (hospital-acquired) infections
Molecular screening of Respiratory pathogens
ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.
lecture notes second med students- Vaccination
Hospital acquired infections/ Nosocomial infections
Prof Frank Peters Dept Family Medicine University of Pretoria
PHARMACOTHERAPY III PHCY 510
lecture notes second med students- Vaccination
بسم الله الرحمن الرحيم.
PHARMACOTHERAPY III PHCY 510
Lower respiratory infections
Blood Culture (Bacterial, Mycobacterial & Fungal)
PCP in adults: Presentation , Treatment and Prophylaxis
PCP: Introduction & Risk Factors
Assessment of Hypoxaemia
PCP: Clinical Presentation
PCP: Diagnosis Dr. Rita O. Oladele Consultant Clinical Microbiologist
PCP: management of co-infection
Pneumococcal infection in adults: burden of disease
Neonatal sepsis in Kilifi
Dr Immaculate Kariuki Consultant Paediatrician Nairobi, Kenya
Use of a multiplex PCR-based reverse line blot (mPCR/RLB) hybridisation assay for the rapid identification of bacterial pathogens  Y. Wang, F. Kong, G.L.
PCP in adults: Presentation , Treatment and Prophylaxis
Cryptococcal Immune Reconstitution Inflammatory Syndrome
Development of two real-time multiplex PCR assays for the detection and quantification of eight key bacterial pathogens in lower respiratory tract infections 
Assessment of Hypoxaemia
PCP: Introduction & Risk Factors
PCP: Diagnosis Dr. Rita O. Oladele Consultant Clinical Microbiologist
MANAGEMENT OF PCP Dr. Akaninyene A. Otu, MBBCh, DTM&H, MPH, MRCP (UK), FWACP University of Calabar Teaching Hospital Calabar, Nigeria.
PCP: Clinical Presentation
Dr Immaculate Kariuki Consultant Paediatrician Nairobi, Kenya
Cryptococcal Immune Reconstitution Inflammatory Syndrome
Human metapneumovirus infection among children in Taiwan: a comparison of clinical manifestations with other virus-associated respiratory tract infections 
Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre.
When to START During an OI
Anthony D Harries Ministry of Health, Malawi
H. M. El Sahly, L.D. Teeter, J.M. Musser, E.A. Graviss 
Predictors of clinical and microbiological treatment failure in patients with methicillin- resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective.
M. Honkinen, E. Lahti, R. Österback, O. Ruuskanen, M. Waris 
G.C. Schito  Clinical Microbiology and Infection 
Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre.
Presentation transcript:

PCP: management of co-infection Dr. Immaculate Kariuki Consultant Paediatrician Nairobi, Kenya

Intended Learning Outcomes To appreciate the diversity and significance of co-infections in patients with PCP

Significance of co-infections Common A frequent cause of clinical failure Present at initial presentation or acquired in critical care units Bias towards respiratory pathogens Lowe D. et al Plos One 2013; 8 (8): 1425 patients from 49 studies, bias towards respiratory pathogens. Lowe D. Pneumocystis jirovecii  Pneumonia in Tropical and Low and Middle Income Countries: A Systematic Review and Meta-Regression.Plos One 2013; 8(8):

Aetiology of co-infections Bacteria: eg S. aureus, S. pneumoniae, K. pneumoniae Mycobacterium tuberculosis Viruses: eg RSV, adenovirus, CMV Morrow et al. The Pediatric Infectious Disease Journal. 29(6):535-539. Morrow pneumonia in South African children with PCP 2006-2008. Of 43 South African children with PCP, 30 (69.8%) were co-infected with another organism. Seventeen (56.7%) were co-infected with CMV, 4 (13.3%) with another virus

Co-infections in non HIV Mainly pulmonary Present in 28-71% of patients Multiple pathogens eg Staphylococcus aureus, gram negative bacteria, Aspergillus sp, CMV CMV still significant In allogeneic hematopoietic stem cell transplant (HSCT) recipients, PCP is associated with CMV pneumonia in around 50% of cases1 1 Slides from ECIL-5 (European council on Infections in Leukemia) 2013

Co-infection with viruses Present in up to 16-40% of HIV infected children with severe all-cause pneumonia Viruses identified include CMV, RSV, influenza, human metapneumovirus, parainfluenza and adenovirus Difficult to make diagnosis out of research settings in low and middle income areas

Cytomegalovirus (1) CMV co-infection has been reported in HIV children with pneumonia on autopsy studies & in 1 out 5 adults with RTI in an autopsy study¹ It is more common in HIV-infected than uninfected children CMV viraemia peaks at age 3-6 months. It is found in high proportion of HIV exposed infants with pneumonia² CMV detectable DNA can be an independent predictor of HIV transmission and mortality in infected individuals and may be an indicator of moderate or severe immunosuppression Mudenda et al Curr Opin Pulm Med2013 May;19(3):229-37 Deaths due to respiratory tract infections in Africa: a review of autopsy studies. 2. Hsiao NYJ Clin Virol. 2013 Sep;58(1):74-8.Cytomegalovirus viraemia in HIV exposed and infected infants: prevalence and clinical utility for diagnosing CMV pneumonia. 

Cytomegalovirus (2) 48% co-infection with PCP in pre ART era and 36% dual infection in ventilated patients¹ CMV pneumonia may be considered in ventilated PCP paediatric patients failing treatment² Histological diagnosis maybe required because its role in pulmonary disease is difficult to assess Treatment : IV gancyclovir 5mg/kg every 12 hours for 14 to 21 days then maintenance at 5mg/kg/day References: Williams AJ, et al. Pneumocystis carinii pneumonia and cytomegalovirus infection in children with vertically acquired HIV infection. AIDS. 2001;15:335–33 2. Goussard P. CMV pneumonia in HIV-infected ventilated infants. Pediatr Pulmonol. 2010 Jul;45(7):650-5.

Bacterial co-infections (1) In most studies of children with severe pneumonia, PCP is a co-infection of bacterial pneumonia Polymicrobial disease associated with higher mortality Blood culture and appropriate antibiotics necessary Higher rates of resistant organisms on nasopharyngeal swabs have been found in association with PCP

Bacterial co-infections (2) Commonly isolated: Streptococcus pneumoniae Staphylococcus aureus Haemophilus influenza Other gram negative bacteria like Klebsiella spp & Escherichia Coli

Tuberculosis (TB) co-infection (1) TB may present as an acute severe pneumonia in infants and young children PCP treatment with steroids has potential to worsen untreated TB Gastric washings and induced sputums routinely done for TB diagnosis can be used for PCP microscopy

Tuberculosis co-infection (2) 5.8% of the patients (2651 adults) had concurrent TB and PCP Low and middle income data on TB/PCP co-infections missing Refence: Castro JG et al Scand J Infect Dis. 2007;39(11-12):1054-8 PCP diagnosis was presumptive & microbiological ( IF & PCR) while TB diagnosis was based on PCR & culture

Summary Pneumocystis pneumonia commonly occurs as a co-infection Other than bacteria co-infections, CMV pneumonia is increasingly being reported in pediatric patients Co-infections compound both diagnosis and management